Courtney Granville is Director of the Center’s initiative to improve patient access to registrational oncology trials. As a collaborative executive leader, her professional career is guided by the utilization of science to inform public health through education, policy and regulatory initiatives. Over the past 3 decades findings from her team’s research programs have informed clinical application/drug repurposing, US legislation, patient and provider education, EPA regulation, NTP-recommended FDA guidelines, and NCCN guidelines. Courtney holds degrees in biology (B.S., Yale College), public health (M.S.P.H., UNC Chapel Hill) and biochemistry and molecular genetics (Ph.D., George Washington University) and has work in government, industry and the non-profit sectors.